Starpharma Holdings reported AUD-4853000 in EBITDA for its fiscal semester ending in December of 2024.


Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast -41273000 20.33M Jun/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024